Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
112 participants
OBSERVATIONAL
2014-05-31
2016-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Rehabilitation After Fast-track Total Knee Arthroplasty
NCT01329081
Length of Stay and Complications in High-risk Patients Receiving Fast-track Total Hip (THA) or Knee- Alloplasty (TKA)
NCT01515670
Does Rehabilitation After Total Hip and Knee Arthroplasty Work
NCT03750448
Thigh Swelling, Hip-muscle Strength, and Functional Performance Following Total Hip Arthroplasty
NCT01246674
Fast-Track vs Conventional for UKA
NCT00284635
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. "Physical function and related factors following discharge from THA and TKA" Luna IE, Kehlet H, Aasvang EK.
2. "Postoperative hypoxemia following fast-track hip and knee arthroplasty" Luna IE, Kehlet H, Aasvang EK.
3. "Cognitive dysfunction after fast-track hip- and knee arthroplasty - prevalence and related factors". Luna IE, Kehlet H, Aasvang EK.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 55 to 80 years
Exclusion Criteria
* Alcohol abuse (\>21 U per week)
* Immunocompromised
* Anticoagulant therapy
* ASA class 4-5
* Functional impairment from psychological or neurological disease
* Sleepapnea
55 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Lundbeck Foundation
OTHER
Rigshospitalet, Denmark
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eske Kvanner Aasvang
MD, DMSci
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Gentofte hospital
Gentofte Municipality, Capital Region, Denmark
Vejle Sygehus
Vejle, Region Syd, Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H-3-2014-005
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.